Report Detail
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth (Status and Outlook) 2019-2024
- RnM3328935 |
- 22 April, 2019 |
- Global |
- 132 Pages |
- LPI(LP Information) |
- Other
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
According to this study, over the next five years the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market by product type, application, key companies and key regions.
This study considers the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Aspirin
Ibuprofen
Celecoxib
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Drug Store
Hospital Pharmacies
Online
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche (including Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical Co
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market by identifying its various subsegments.
Focuses on the key global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2014-2024
- 2.1.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Region
- 2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type
- 2.2.1 Aspirin
- 2.2.2 Ibuprofen
- 2.2.3 Naproxen
- 2.2.4 Celecoxib
- 2.2.5 Others
- 2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
- 2.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (2014-2019)
- 2.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application
- 2.4.1 Drug Store
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online
- 2.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
- 2.5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Application (2014-2019)
3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Players
- 3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Players
- 3.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Players (2017-2019)
- 3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Players (2017-2019)
- 3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Regions
- 4.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions
- 4.2 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth
- 4.3 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth
- 4.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth
- 4.5 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth
5 Americas
- 5.1 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Countries
- 5.2 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
- 5.3 Americas Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Countries
- 6.2 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
- 6.3 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries
- 7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
- 7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries
- 8.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
- 8.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
- 10.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast (2019-2024)
- 10.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Regions
- 10.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Type
- 10.8 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Application
11 Key Players Analysis
- 11.1 Roche (including Genentech)
- 11.1.1 Company Details
- 11.1.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
- 11.1.3 Roche (including Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Roche (including Genentech) News
- 11.2 Amgen
- 11.2.1 Company Details
- 11.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
- 11.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Amgen News
- 11.3 B-MS
- 11.3.1 Company Details
- 11.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
- 11.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 B-MS News
- 11.4 Merck
- 11.4.1 Company Details
- 11.4.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
- 11.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Merck News
- 11.5 Pfizer
- 11.5.1 Company Details
- 11.5.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
- 11.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Pfizer News
- 11.6 Novartis
- 11.6.1 Company Details
- 11.6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
- 11.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Novartis News
- 11.7 Eli Lilly and Company
- 11.7.1 Company Details
- 11.7.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
- 11.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Eli Lilly and Company News
- 11.8 Johnson & Johnson
- 11.8.1 Company Details
- 11.8.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
- 11.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Johnson & Johnson News
- 11.9 GSK
- 11.9.1 Company Details
- 11.9.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
- 11.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 GSK News
- 11.10 Sanofi
- 11.10.1 Company Details
- 11.10.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
- 11.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Sanofi News
- 11.11 Boehringer Ingelheim
- 11.12 Zhejiang Jiuzhou Pharmaceutical Co
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) . Industry analysis & Market Report on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is a syndicated market report, published as Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
